HPV vaccines

General indicators

- Type, including severity, consequences and frequency of short- and long-term adverse events following vaccination
- Perception of the target population on the risk of disease
- Acceptability of the vaccine and of vaccination against the disease
- Available vaccines, licensing status, prequalification status, presentation, formulation, dosage and route of administration
- Number of doses and timing of administrations
- Cold chain volume required per vaccine dose (in cm3)

Outbreak, epidemic or pandemic risk

Not applicable for HPV

Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register

National Immunization Technical Advisory Groups

Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network

Legal Notice

Subscription to the monthly updates

At the end of each month, we share the latest NITAG recommendations from across all regions, highlight key articles related to NITAG activities, and provide important announcements. Stay informed - don’t miss out!